Loading...
Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
BACKGROUND: There is little evidence of combining sorafenib with hepatic arterial infusion chemotherapy (HAIC) after transarterial chemoembolization (TACE) for intermediate and advanced hepatocellular carcinoma (HCC). It is important to identify that patients with intermediate and advanced HCC are m...
Na minha lista:
| Udgivet i: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Baishideng Publishing Group Inc
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7341000/ https://ncbi.nlm.nih.gov/pubmed/32699581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i6.663 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|